It?s well-known that unprotected sun exposure significantly heightens risk for skin cancer, but a study published in the current issue of Dermatologic Surgery showed that a new topical cream can remove common pre-cancerous skin lesions with a reduced rate of recurrence compared with other therapies.
AIDS patients with a disfiguring skin complication caused by HIV infection can be treated safely and successfully with applications of an inexpensive silicone oil preparation, according to research reported in Dermatologic Surgery, the medical journal of the American Society for Dermatologic Surgery (ASDS).
The U.S. Food and Drug Administration (FDA) advisory committee recently approved SCULPTRA (injectable poly-L-lactic acid) for use in correcting shape and contour deficiencies resulting from facial fat loss (lipoatrophy) in people with human immunodeficiency virus (HIV).
Under the Food and Drug Administration’s (FDA) “Consumer Health for Better Nutrition Initiative,” the Agency is announcing the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer. Based on a systematic evaluation of the available scientific data, the FDA intends to consider exercising its enforcement discretion for the following qualified health claims for breast and prostate cancer:
Strength training may help ease the pain and immobility caused by hip arthritis, a new study suggests.
Day care facilities were shown to be an important source for allergen exposure, according to a study featured on the online version of the Journal of Allergy & Clinical Immunology (JACI). The JACI is the peer-reviewed journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).
Eyelid surgery (technically called blepharoplasty) is a procedure to remove fat–usually along with excess skin and muscle from the upper and lower eyelids.
A promising new drug candidate that may be effective against both actively dividing and slow-growing Mycobacterium tuberculosis (M. tb) has begun testing in humans, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced today. The novel antibiotic, PA-824, may shorten the time needed to treat tuberculosis (TB), a contagious disease that claims approximately two million lives worldwide each year. In partnership with the non-profit New York-based Global Alliance for TB Drug Development (TB Alliance), NIAID contributed to the drug candidate?s preclinical safety and efficacy testing in animal models. Now, a clinical trial to assess PA-824?s safety, sponsored by the TB Alliance, has opened at a medical clinic in Lincoln, NE.
Many of the medications widely used to manage chronic insomnia have not yet been rigorously evaluated for long-term use, according to an independent scientific panel convened this week by the National Institutes of Health. This is a critical consideration because for many patients, insomnia can persist for decades. The panel also stressed that many chronic insomnia sufferers could benefit from currently underused behavioral and cognitive therapies.
A significantly lower risk of heart disease can now be added to the list of proven long-term benefits of tight glucose control in people with type 1 diabetes. Researchers announced this finding today at the annual scientific meeting of the American Diabetes Association after analyzing cardiovascular (CVD) events such as heart attack, stroke, and angina in patients who took part in the Diabetes Control and Complications Trial (DCCT) years ago.